13. Operating expenses by nature
|
|
|
Year ended December 31, |
|
|||||||||
|
in USD ‘000 |
|
2017 |
|
|
2016 |
|
|
2015 |
|
|||
|
External research and development costs |
|
|
43,268 |
|
|
|
16,811 |
|
|
|
10,784 |
|
|
Staff costs (note 14) |
|
|
17,999 |
|
|
|
7,436 |
|
|
|
7,313 |
|
|
Professional fees |
|
|
2,862 |
|
|
|
4,016 |
|
|
|
743 |
|
|
Rents |
|
|
592 |
|
|
|
427 |
|
|
|
367 |
|
|
Travel expenses |
|
|
1,073 |
|
|
|
541 |
|
|
|
313 |
|
|
Patent registration costs |
|
|
426 |
|
|
|
512 |
|
|
|
87 |
|
|
Depreciation |
|
|
70 |
|
|
|
46 |
|
|
|
36 |
|
|
Other |
|
|
1,190 |
|
|
|
374 |
|
|
|
203 |
|
|
Total operating expenses by nature |
|
|
67,480 |
|
|
|
30,163 |
|
|
|
19,846 |
|
Due to the difficulty in assessing when research and development projects would generate revenue, the Group expenses all research and development costs on the consolidated statement of comprehensive loss. In 2017, research and development expenses amounted to USD 54.9 million (2016: USD 23.7 million, 2015: USD 16.9 million).
The depreciation expense has been allocated as follows:
|
|
|
Year ended December 31, |
|
|||||||
|
in USD ‘000 |
|
2017 |
|
2016 |
|
|
2015 |
|
||
|
Research and development expenses |
|
44 |
|
|
35 |
|
|
|
28 |
|
|
General and administrative expenses |
|
26 |
|
|
11 |
|
|
|
8 |
|
|
Total depreciation |
|
70 |
|
|
46 |
|
|
|
36 |
|